Inetetamab for Injection in Combination with Vinorelbine Weekly or Every Three Weeks in HER2-positive Metastatic Breast Cancer: A Multicenter, Randomized, Phase II Clinical Trial
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE(2024)
Key words
metastatic breast cancer,pharmacokinetics,safety,efficacy,immunogenicity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined